These findings help explain why two people on the same medication can have very different experiences, but they dont change how medications are prescribed today
pubmed.ncbi.nlm.nih.gov/37366315 UK regulatory status retatrutide is an unlicensed investigational compound supplied strictly for research, not human consumption, as of 2026.
Not dangerous
We address the root causes of B12 deficiencysuch as dietary restrictions, gastrointestinal issues, or chronic health conditionsusing the latest evidence-based protocols for safe and effective treatment
00:02:33 Steve Small: Delayed stomach emptying effect can be helpful here, since it can make patients feel fuller, faster, and eat less overall
The medication is administered as a once-weekly injection, with the dose gradually increased to maximize benefits and minimize side effects